2015
DOI: 10.1177/0192623315595883
|View full text |Cite
|
Sign up to set email alerts
|

Juvenile Toxicology

Abstract: The Society of Toxicologic Pathology (STP) Education Committee and the STP Reproductive Special Interest Group held a North Carolina regional meeting entitled, “Juvenile Toxicology: Relevance and Challenges for Toxicologists and Pathologists” on March 13, 2015, at the National Institute of Environmental Health Sciences/National Toxicology Program in Research Triangle Park, North Carolina. The purpose of this regional meeting was to familiarize attendees with the topic of juvenile toxicity testing and discuss i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
5
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 11 publications
(5 citation statements)
references
References 70 publications
0
5
0
Order By: Relevance
“…The interest and increased numbers of juvenile animal toxicity tests reflect a growing need to predict chemical hazards in pediatric populations 12 . Juvenile kidney studies are emphasized because of the kidney’s ongoing postnatal periods of development and maturation 13 .…”
Section: Introductionmentioning
confidence: 99%
“…The interest and increased numbers of juvenile animal toxicity tests reflect a growing need to predict chemical hazards in pediatric populations 12 . Juvenile kidney studies are emphasized because of the kidney’s ongoing postnatal periods of development and maturation 13 .…”
Section: Introductionmentioning
confidence: 99%
“…Pathologists and toxicologists are increasingly confronted with the challenging task of distinguishing potential exposure related histologic lesions from normal maturation changes associated with puberty in juvenile animals (Remick et al, 2015). There has been an increased need for toxicity safety assessments in juvenile animals, as a result of new requirements for the safe use of pharmaceuticals in pediatric patients, stemming from the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA) passed by the United States Federal Drug Administration (USFDA) in 2002 and 2003, respectively.…”
Section: Introductionmentioning
confidence: 99%
“…Recently, juvenile toxicity testing has become a topic of interest for pathologists, and the challenges in evaluating juvenile toxicity studies have been discussed 1 . These challenges include how to assess and interpret histopathological changes in tissues from juvenile animals.…”
mentioning
confidence: 99%